NObreath

FeNO Breath Analyzer measures fractional exhaled nitric oxide (FeNO) levels to assess airway inflammation and aid in asthma diagnosis and management. The device provides rapid, non-invasive testing suitable for clinical settings and respiratory clinics.

A diagnostic device that measures fractional exhaled nitric oxide and carbon monoxide levels to aid in asthma diagnosis and respiratory assessment. This monitor helps healthcare professionals evaluate airway inflammation and respiratory health.

Portable exhaled nitric oxide (FeNO) monitoring system enabling rapid breath testing in approximately 6 seconds. Used for detection and classification of respiratory conditions including asthma and airway inflammation.

Diagnostic equipment measuring exhaled nitric oxide (eNO) levels as a biomarker for airway inflammation and asthma assessment. Supports non-invasive evaluation of respiratory disease status.

A diagnostic device for asthma diagnosis, providing simplified testing and diagnosis for asthma management.

Portable fractional exhaled nitric oxide (FeNO) monitoring system that performs breath testing in 6 seconds for non-invasive cardiorespiratory disease detection and classification.

Device measuring fractional exhaled nitric oxide levels. Useful in assessing airway inflammation in asthma and other inflammatory airway diseases.

Vyntus™ FENO is a medical device that measures fractional exhaled nitric oxide (FeNO) during exhalation to conveniently and accurately assess airway inflammation. Exhaled nitric oxide is a biomarker closely associated with inflammatory respiratory diseases, allowing clinicians to quantify the level of airway inflammation and effectively utilize the measurement for disease diagnosis and monitoring treatment response. Based on its intuitive user interface and reliable measurement technology, Vyntus™ FENO provides healthcare professionals with rapid and highly dependable test results.

System for analyzing biomarkers in exhaled breath samples. Enables non-invasive assessment of airway inflammation and disease activity.

A non-invasive diagnostic platform utilizing exhaled breath analysis to evaluate inflammatory markers associated with respiratory and digestive diseases. Provides an alternative to blood tests and imaging for disease screening and monitoring.

Diagnostic tool measuring nasal airway resistance and obstruction severity in sleep apnea patients. Guides treatment selection between CPAP interfaces and surgical interventions. Provides objective data on nasal anatomy impact.

A diagnostic system designed to analyze exhaled air and identify biomarkers relevant to patient health status. The system enables non-invasive assessment of various physiological conditions through breath analysis technology.